WebDisclosure WebDisclosure
Basculer en Français
9893 Companies
199209 Keywords
130101 Articles
105879 Press releases
Headlines Articles Press releases Prolacta Bioscience Remove
  1. Home
  2. Companies
  3. Prolacta Bioscience
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/19/2026 at 08:10, 3 hours 54 minutes ago

    Japan Approves Prolacta's Human Milk Fortifiers as Prescription Drug

    Neonatal Care Japan Approval Infant Nutrition Prolacta Human Milk-based
  • BRIEF

    published on 02/19/2026 at 08:10, 3 hours 54 minutes ago

    Le Japon approuve les fortifiants de lait maternel de Prolacta comme médicament sur ordonnance

    Soins Néonatals Approbation Du Japon Nutrition Infantile Prolacta À Base De Lait Maternel
  • PRESS RELEASE

    published on 02/19/2026 at 08:05, 3 hours 59 minutes ago

    A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants

    Japan approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as Prescription Drug for Vulnerable Infants, supported by clinical evidence and regulatory milestones
    Japan Neonatal Care Prolacta Bioscience 100% Human Milk-Based Fortifiers Prescription Drug
    Logo of Prolacta Bioscience
Accesswire
  • Published on 02/19/2026 at 12:00, 4 minutes ago

    PJX Resources Discovers a Third Large Target Area with Sullivan Style Sedex Deposit Potential on the Dewdney Trail Property in Southeastern British Columbia

  • Published on 02/19/2026 at 09:01, 3 hours 3 minutes ago

    Formation Metals Appoints Roger Rosmus to Newly Established Advisory Board

  • Published on 02/19/2026 at 05:30, 6 hours 34 minutes ago

    Troubadour Announces Correction to Warrant Exercise Price

  • Published on 02/18/2026 at 23:15, 12 hours 49 minutes ago

    Silver Wolf Mobilizes Drill Rig at Ana Maria

  • Published on 02/18/2026 at 22:00, 14 hours 4 minutes ago

    Nextech3D.ai Delivers Q3 +59% YoY Revenue Growth and +20% Sequential Gain With Record 95% Gross Margins; Operating Loss Improved by 46% ($696K) As Company Enters New AI‑Driven Growth Cycle

View all ACCESSWIRE
EQS Group
  • Published on 02/19/2026 at 11:48, 15 minutes ago

    Vossloh supplies railway sleepers for Norway

  • Published on 02/19/2026 at 11:34, 30 minutes ago

    Amundi Physical Metals plc: UK Final Terms

  • Published on 02/19/2026 at 11:30, 34 minutes ago

    Amundi Physical Metals plc: Final Terms

  • Published on 02/19/2026 at 11:25, 39 minutes ago

    Evolveum to Showcase AI-Driven Acceleration of IGA Application Onboarding at Gartner IAM Summit 2026

  • Published on 02/19/2026 at 11:05, 59 minutes ago

    Phemex Launches AI-Native Revolution, Signaling Full-Scale AI Transformation

View all EQS
Les Echos
  • Published on 02/19/2026 at 07:30, 4 hours 34 minutes ago

    Résultats Annuels 2025 : Des résultats supérieurs aux objectifs 2025

  • Published on 02/19/2026 at 07:30, 4 hours 34 minutes ago

    Full-Year 2025 Results: Solid results above 2025 guidance

  • Published on 02/19/2026 at 07:00, 5 hours 4 minutes ago

    Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months

  • Published on 02/19/2026 at 07:00, 5 hours 4 minutes ago

    Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months

  • Published on 02/19/2026 at 07:00, 5 hours 4 minutes ago

    Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy